Akt activity in Alzheimer's disease and other neurodegenerative disorders

NeuroReport

Volumn 15, Issue 6, 2004, Pages 955-959

  Rickle, Annika ^a   Bogdanovic, Nenad ^a   Volkman, Inga ^a   Winblad, Bengt ^a   Ravid, Rivka ^b   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

Akt; Alzheimer's disease; Apoptosis; IGF I; Post mortem brain

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HYBRID PROTEIN; PROTEIN KINASE B; PROTEIN SERINE KINASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MACROGLIA; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TEMPORAL LOBE;

EID: 2342558065     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200404290-00005     Document Type: Article

References (12)

1. Russell JW, Windebank AJ, Schenone A and Feldman EL. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J Neurobiol 36, 455-467 (1998).
2. Brazil DP and AH. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 6, 657-664 (2001).
3. Grimes CA and Jope RS. The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. Prog Neurobiol 65, 391-426 (2001).
4. Bhat RV and Budd SL. GSK3beta signalling: casting a wide net in Alzheimer's disease. Neurosignals 11, 251-261 (2002).
5. Pei J-J, Tanaka T, Tung Y-C, Braak E, Iqbal K and Grundke-Iqbal I. Distribution, levels and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. Neuropathol Exp Neurol 56, 70-78 (1997).
6. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58, 1010-1019 (1999).
7. Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M et al. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 31, 317-323 (1998).
8. Dore S, Kar S, Zheng WH and Quirion R. Protective and rescuing abilities of IGF-I and some putative free radical scavengers against beta-amyloid-inducing toxicity in neurons. Ann NY Acad Sci 890, 356-364 (1999).
9. Phiel CJ, Wilson CA, Lee VM and Klein PS. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423, 435-439 (2003).
10. Li B, Ryder J, Su Y, Zhou Y, Liu F and Ni B. FRAT1 peptide decreases Abeta production in swAPP(751) cells. FEBS Lett 553, 347-350 (2003).
11. Pei JJ, Khatoon S, An WL, Nordlinder M, Tanaka T, Braak H et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol 105, 381-392 (2003).
12. Ferrer I, Barrachina M and Puig B. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Acta Neuropathol 104, 583-591 (2002).